Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models

SARS-CoV-2 is the coronavirus that causes the respiratory disease COVID-19, which is now the third-leading cause of death in the United States. The FDA has recently approved remdesivir, an inhibitor of SARS-CoV-2 replication, to treat COVID-19, though recent data from the WHO shows little to no bene...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:bioRxiv
Autors principals: Li, Xiaoquan, Lidsky, Peter, Xiao, Yinghong, Wu, Chien-Ting, GarciaKnight, Miguel, Yang, Junjiao, Nakayama, Tsuguhisa, Nayak, Jayakar V., Jackson, Peter K., Andino, Raul, Shu, Xiaokun
Format: Artigo
Idioma:Inglês
Publicat: Cold Spring Harbor Laboratory 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7605555/
https://ncbi.nlm.nih.gov/pubmed/33140048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.10.28.359042
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars